Comparison between Syndicate Bank FPO and Vivimed Labs IPO.
Syndicate Bank FPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Vivimed Labs IPO is a Mainboard Fixed Price proposed to list at BSE, NSE.
The total issue size of Syndicate Bank FPO is up to ₹250.00 Cr whereas the issue size of the Vivimed Labs IPO is up to ₹17.51 Cr. The final issue price of Syndicate Bank FPO is ₹50.00 per share and of Vivimed Labs IPO is ₹70.00 per share.
| Syndicate Bank FPO | Vivimed Labs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹46.00 per share | |
| Issue Price (Upper) | ₹50.00 per share | |
| Issue Price (Final) | ₹50.00 per share | ₹70.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 5,00,00,000 shares | 25,01,429 shares |
| Fresh Issue Size (Amount) | up to ₹250.00 Cr | up to ₹17.51 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,00,00,000 shares | 25,01,429 shares |
| Issue Size Total (Amount) | up to ₹250.00 Cr | up to ₹17.51 Cr |
Syndicate Bank FPO opens on Jul 07, 2005, while Vivimed Labs IPO opens on Jul 09, 2005. The closing date of Syndicate Bank FPO and Vivimed Labs IPO is Jul 13, 2005, and Jul 13, 2005, respectively.
Syndicate Bank FPO P/E ratio is , as compared to Vivimed Labs IPO P/E ratio of .
| Syndicate Bank FPO | Vivimed Labs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 73.52 | 55.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.47 | 36.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 25.79 | 23.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Syndicate Bank FPO Retail Individual Investors (RII) are offered 1,57,50,000 shares while in Vivimed Labs IPO retail investors are offered 1,57,50,000 shares. Qualified Institutional Buyers (QIB) are offered 2,25,00,000 shares in Syndicate Bank FPO and 0 shares in Vivimed Labs IPO.
| Syndicate Bank FPO | Vivimed Labs IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 2,25,00,000 shares | 0 shares |
| NII | 67,50,000 shares | 9,25,000 shares |
| RII | 1,57,50,000 shares | 9,25,000 shares |
| Employee | 50,00,000 shares | 50,000 shares |
| Others | ||
| Total | 5,00,00,000 shares | 25,00,000 shares |
Syndicate Bank FPO subscribed in total, whereas Vivimed Labs IPO subscribed .
